SPI1 and Alzheimer disease: In this study on the functional effect of modulating SPI1 levels on AD pathology in vivo, we demonstrate that Spi1 knockdown significantly exacerbates amyloid and other associated pathologies, whereas Spi1 overexpression ameliorates these phenotypes.